Immunohistochemistry showed that IGF2BP3 was expressed in 27–55% of cases of primary pulmonary adenocarcinoma and in 75–90% of cases of squamous cell carcinoma of the lung [29]. The gene discussed is IGF2BP3; the disease is squamous cell lung carcinoma.